| CAT No: | CL-CIZP-03 |
| CAS No: | 90139-06-3 |
| Mol.F: | C20H27N3O5 |
| Mol.Wt.: | 389.5 |
| Chemical Name: | (1S,9S)-9-[[(S)-1-carboxy-3-phenylpropyl]amino]-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Cilazapril EP Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Cilazapril EP Impurity B is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(1S,9S)-9-[[(S)-1-carboxy-3-phenylpropyl]amino]-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Cilazapril Molecular Formula: C20H27N3O5
Molecular Weight: 389.5
Storage: Store in a cool, dry place.
| Product Name: | Cilazapril EP Impurity B |
| CAS No: | 90139-06-3 |
| Mol.F.: | C20H27N3O5 |
| Mol.Wt.: | 389.5 |
Cat. No: CL-CIZP-NO-01
CAS No: NA
Mol. F: C22H30N4O6
Mol. Wt: 446.5
Inv. Status: Custom Synthesis
Cat. No: CL-CIZP-01
CAS No: 88768-40-5
Mol. F: C22H31N3O5
Mol. Wt: 417.5
Inv. Status: Custom Synthesis
Cat. No: CL-CIZP-02
CAS No: 106860-19-9
Mol. F: C26H39N3O5
Mol. Wt: 473.6
Inv. Status: Custom Synthesis
Cat. No: CL-CIZP-04
CAS No: 1905397-51-4
Mol. F: C24H35N3O5
Mol. Wt: 445.6
Inv. Status: Custom Synthesis
Cat. No: CL-CIZP-05
CAS No: 106928-09-0
Mol. F: C22H31N3O5
Mol. Wt: 417.5
Inv. Status: Custom Synthesis
Cat. No: CL-CIZP-06
CAS No: NA
Mol. F: C32H41N3O7
Mol. Wt: 579.7
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: